BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30107961)

  • 1. Cortactin as a potential predictor of second esophageal neoplasia in hypopharyngeal carcinoma.
    Lien CF; Hwang TZ; Lin TM; Liu KW; Lin BS; Wang CC; Yang CC; Yeh SA
    Auris Nasus Larynx; 2019 Apr; 46(2):260-266. PubMed ID: 30107961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancers.
    Avincsal MO; Jimbo N; Fujikura K; Shinomiya H; Otsuki N; Morimoto K; Furukawa T; Morita N; Maehara R; Itoh T; Nibu KI; Zen Y
    Histopathology; 2018 Apr; 72(5):826-837. PubMed ID: 29143365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.
    Wang YK; Chuang YS; Wu TS; Lee KW; Wu CW; Wang HC; Kuo CT; Lee CH; Kuo WR; Chen CH; Wu DC; Wu IC
    Int J Cancer; 2017 Nov; 141(10):1987-1996. PubMed ID: 28758200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer.
    Lu P; Qiao J; He W; Wang J; Jia Y; Sun Y; Tang S; Fu L; Qin Y
    PLoS One; 2014; 9(2):e88918. PubMed ID: 24551190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
    Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
    Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma.
    Kim EK; Cho YA; Koh YW; Shin HA; Cho BC; Yoon SO
    BMC Cancer; 2020 Apr; 20(1):348. PubMed ID: 32326908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
    Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Synchronous ESCN in Head and Neck Cancer: A Single-Institution Perspective.
    Thakur K; Singh CA; Thakar A; Kakkar A; Sikka K; Kumar R; Sharma SC
    Laryngoscope; 2021 Mar; 131(3):E807-E814. PubMed ID: 32619324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
    Iwatsubo T; Ishihara R; Morishima T; Maekawa A; Nakagawa K; Arao M; Ohmori M; Iwagami H; Matsuno K; Inoue S; Nakahira H; Matsuura N; Shichijo S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Miyashiro I; Higuchi K; Fujii T
    BMC Cancer; 2019 Jan; 19(1):3. PubMed ID: 30606157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Ruiz-Ávila I; Gil-Montoya JA
    Head Neck; 2019 Jun; 41(6):1963-1978. PubMed ID: 30597652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the early detection of esophageal neoplasms in hypopharyngeal cancer patients treated with concurrent chemoradiotherapy.
    Watanabe S; Ogino I; Inayama Y; Sugiura M; Sakuma Y; Kokawa A; Kunisaki C; Inoue T
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e3-e10. PubMed ID: 25359448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck cancer arising after endoscopic mucosal resection for squamous cell carcinoma of the esophagus.
    Shimizu Y; Tsukagoshi H; Fujita M; Hosokawa M; Watanabe A; Kawabori S; Kato M; Sugiyama T; Asaka M
    Endoscopy; 2003 Apr; 35(4):322-6. PubMed ID: 12664389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of REG III and prognosis in head and neck cancer.
    Masui T; Ota I; Itaya-Hironaka A; Takeda M; Kasai T; Yamauchi A; Sakuramoto-Tsuchida S; Mikami S; Yane K; Takasawa S; Hosoi H
    Oncol Rep; 2013 Aug; 30(2):573-8. PubMed ID: 23743605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis.
    Pujol A; Llansana A; Pérez-Ugarte L; Sauter B; Quer M; León X
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(6):339-345. PubMed ID: 37149128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients.
    Chen WC; Wu CN; Wang YM; Chiu TJ; Wu SC; Yang YH; Luo SD
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):141-150. PubMed ID: 37727942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study.
    Gong EJ; Kim DH; Ahn JY; Choi KS; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY
    Dis Esophagus; 2016 Oct; 29(7):752-759. PubMed ID: 26471351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene sequencing and expression of Raf-1 in lymphatic metastasis of hypopharyngeal carcinoma.
    Li Y; Lu T; Hu G
    Cancer Biomark; 2020; 28(2):181-191. PubMed ID: 32224526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis.
    Hsu NY; Yeh KT; Chiang IP; Pai LY; Chen CY; Ho HC
    Dis Esophagus; 2008; 21(5):402-8. PubMed ID: 19125793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of GRP78/BiP expression in patients with Stage III/IV hypopharyngeal squamous cell carcinoma.
    Kaira K; Toyoda M; Shimizu A; Imai H; Sakakura K; Nikkuni O; Suzuki M; Iijima M; Asao T; Chikamatsu K
    Neoplasma; 2016; 63(3):477-83. PubMed ID: 26952514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.